| P2093 | author name string | A Soulier | |
| | D Dhumeaux | |
| | G Germanidis | |
| | J M Pawlotsky | |
| | M Bouvier | |
| | M Pellerin | |
| | P O Frainais | |
| P2860 | cites work | CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 |
| | Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein | Q24319002 |
| | The neighbor-joining method: a new method for reconstructing phylogenetic trees | Q25939010 |
| | Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. | Q43036717 |
| | Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region | Q43037314 |
| | Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection. | Q43038463 |
| | Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis | Q43040287 |
| | Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees | Q43041585 |
| | Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection | Q43048866 |
| | Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis | Q43048989 |
| | Quantitation of hepatitis C virus RNA in liver transplant recipients | Q43049255 |
| | Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. | Q43049265 |
| | Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins | Q43049359 |
| | Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus | Q44781061 |
| | Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I | Q45752944 |
| | Antigenic oscillations and shifting immunodominance in HIV-1 infections. | Q45869472 |
| | Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. | Q52249518 |
| | Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials | Q73717402 |
| | Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group | Q74428457 |
| | Confidence Limits on Phylogenies: an Approach using the Bootstrap | Q26778379 |
| | Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy | Q27469352 |
| | Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation | Q27469500 |
| | Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection | Q27469524 |
| | Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. | Q27469549 |
| | Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations | Q27469554 |
| | Evolution of hypervariable region 1 of hepatitis C virus in primary infection | Q27469585 |
| | Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway | Q27469729 |
| | Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region | Q27478292 |
| | Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses | Q27478447 |
| | Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection | Q27485921 |
| | Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses | Q27485952 |
| | Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus | Q27486056 |
| | Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution | Q27486234 |
| | Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 |
| | Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group | Q27861083 |
| | Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization | Q29615898 |
| | Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections | Q29615900 |
| | MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers | Q29617499 |
| | Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 |
| | Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group | Q29620719 |
| | Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins | Q29620952 |
| | The interferons. Mechanisms of action and clinical applications | Q36677129 |
| | Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance | Q39577975 |
| | RNA virus quasispecies: significance for viral disease and epidemiology | Q40574716 |
| | Hepatitis C virus infection: virus/host interactions | Q40837574 |
| | Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity | Q41006162 |
| | Actions of cytokines on the immune response and viral interactions: an overview | Q41006613 |
| | New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine | Q41354692 |
| | Therapy of hepatitis C: overview | Q41598802 |
| | A French consensus conference on hepatitis C: screening and treatment | Q41651187 |
| | The role of immune responses in the pathogenesis of hepatitis C virus infection | Q41681577 |
| | Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group | Q42977051 |
| | Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. | Q42977254 |
| | The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy | Q42979949 |
| | Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy | Q42980301 |
| | Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy | Q42980894 |
| | Hepatitis C virus replication during acute infection in the chimpanzee | Q42981539 |
| | Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients | Q42981962 |
| | Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon | Q42982877 |
| | Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy | Q42985646 |
| | Differences in hypervariable region 1 quasispecies between immune complexed and non-immune complexed hepatitis C virus particles | Q42985856 |
| | Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. | Q42987547 |
| | 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. | Q42990190 |
| | The mechanisms of chronicity in hepatitis C virus infection | Q42990521 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| | hepatitis C | Q154869 |
| | patient | Q181600 |
| | Hepatitis C virus | Q708693 |
| | protein evolution | Q59870539 |
| P304 | page(s) | 6490-9 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy | |
| P478 | volume | 73 | |